Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A phase I study of an oral formulation of ixabepilone (ixa) in patients with advanced cancer He, A. R., Kunz, P. L., Pishvaian, M. J., Colevas, A. D., Hwang, J. J., Clemens, P. L., Messina, M., Kaleta, R., Abrahao, F., Sikic, B. I. AMER SOC CLINICAL ONCOLOGY. 2010
View details for DOI 10.1200/jco.2010.28.15_suppl.e13090
View details for Web of Science ID 000208852000315